Status:

COMPLETED

Efficacy and Safety of Vaccination Against COVID-19 in Neuromuscular Patients

Lead Sponsor:

University Hospital, Bordeaux

Conditions:

Neuromuscular Diseases

Eligibility:

All Genders

18-100 years

Brief Summary

The frequency of severe forms of COVID-19 is higher in people with neuromuscular disease and in severe cases and long hospital stays, the disability of some neuromuscular patients may worsen due to pr...

Detailed Description

Prevention of COVID-19 in neuromuscular patients is therefore fundamental and vaccination is eagerly awaited by patients and their healthcare teams. An unprecedented research effort has made it possib...

Eligibility Criteria

Inclusion

  • Patient with one of the following neuromuscular diseases:
  • Autoimmune myasthenia gravis, Lambert-Eaton syndrome
  • Congenital myasthenic syndromes
  • Myositis
  • Inflammatory neuropathies
  • Hereditary neuropathies (Charcot-Marie-Tooth disease, etc.)
  • Amyloid neuropathies
  • Spinal atrophies
  • Myotonic dystrophies type 1 (Steinert disease) and 2 (PROMM)
  • Duchenne and Becker muscular dystrophies
  • Muscular dystrophies of the girdles
  • Pump disease
  • Congenital myopathies
  • Congenital muscular dystrophies
  • Metabolic myopathies
  • Other myopathies with confirmed genetic diagnosis
  • Patient over 18 years old
  • Patient having understood that the follow-up of a possible side effect of the vaccination or of a COVID-19 must be carried out by his usual doctor (s) and not by the observatory team Va-C-NEMUS
  • Patients having been informed of the study and having expressed their agreement

Exclusion

  • 1\. Patient under legal protection, curatorship or tutorship

Key Trial Info

Start Date :

March 11 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 3 2023

Estimated Enrollment :

1388 Patients enrolled

Trial Details

Trial ID

NCT05311904

Start Date

March 11 2021

End Date

February 3 2023

Last Update

October 6 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU de Bordeaux

Bordeaux, France, 33076

Efficacy and Safety of Vaccination Against COVID-19 in Neuromuscular Patients | DecenTrialz